Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
STAT+
Coronavirus
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Morning Rounds
STAT+

STAT+ Conversations: A Morning Rounds year-in-review

  • Shraddha Chakradhar

By Shraddha Chakradhar Dec. 8, 2020

Reprints

Editor’s note: A recording of the conversation is embedded below. 

Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma and health tech leaders. This week, STAT’s co-founder and executive editor, Rick Berke, is joined by Morning Rounds writer Shraddha Chakradhar to discuss the best and most interesting stories featured in STAT’s daily newsletter through this year unlike any other. 

advertisement

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Shraddha Chakradhar

Shraddha Chakradhar

Reporter, Morning Rounds Writer, Intern Coordinator

Shraddha writes the Morning Rounds newsletter and covers health and medicine.

The tragedy of the Golden Gate Bridge’s $400 million…
The tragedy of the Golden Gate Bridge’s $400 million anti-suicide net
Tired of ‘dead end’ approach, herpes patients mobilize to…
Tired of ‘dead end’ approach, herpes patients mobilize to demand government action
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
STAT Conversation: The Whitest Medical Specialty
STAT Conversation: The Whitest Medical Specialty
STAT+ Conversation: The ‘Shroom Boom’
STAT+ Conversation: The ‘Shroom Boom’
STAT+ Conversation: Drug pricing drama
STAT+ Conversation: Drug pricing drama

Recommended Stories